Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arch Dis Child ; 97(11): 982-4, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22863689

RESUMEN

PURPOSE: The Cystic Fibrosis Trust in 2007 published a recommended target of 75-150 nmol/L for 25-hydroxyvitamin D (25-OHD). In 2008 we found that only 10% of pancreatic insufficient (PI) children met this target. An increase in supplementation was implemented and a repeat audit performed in 2010. METHODS: PI children ≥1 year under sole-care in our regional centre were included. Vitamin D3 supplementation increased by >450% to either 3800 IU/day liquid or 800 IU daily plus 20,000 IU weekly tablets. In 2010 pancreatic sufficient (PS) children were also audited separately. RESULTS: The median 25-OHD level increased from 51.5 nmol/L in 2008 (n=78, 10% >75 nmol/L) to 72 nmol/L in 2010 (n=72, 51% >75 nmol/L), p<0.0001. In PS children (n=15 in 2010) 87% had 25-OHD levels <75 nmol/L. CONCLUSIONS: A substantial increase in supplementation led to a significant increase in 25-OHD levels but around half still failed to reach the recommended target.


Asunto(s)
Calcifediol/sangre , Fibrosis Quística/sangre , Insuficiencia Pancreática Exocrina/tratamiento farmacológico , Deficiencia de Vitamina D/tratamiento farmacológico , Adolescente , Calcifediol/uso terapéutico , Niño , Preescolar , Fibrosis Quística/complicaciones , Fibrosis Quística/fisiopatología , Suplementos Dietéticos , Insuficiencia Pancreática Exocrina/etiología , Humanos , Lactante , Auditoría Médica , Deficiencia de Vitamina D/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA